[关于红血病患者在ICU获得的虚弱的研究进展]
Huiyao Chen1, Xingsong Li, Lixin Zhou
1Department of Critical Care Medicine, the First People's Hospital of Foshan, Foshan 528000, Guangdong, China. Corresponding author: Chen Huiyao,
Zhonghua wei zhong bing ji jiu yi xue
|February 19, 2025
概括
在ICU获得的衰弱 (ICU-AW) 影响了超过50%的败血症幸存者,影响了长期的生活质量. 早期康复是ABCDEF捆绑策略的核心部分,对于预防和管理毒症患者的ICU-AW至关重要.
科学领域:
- 关键护理医学 关键护理医学
- 神经学 神经学
- 康复医学是康复的医学.
背景情况:
- 败血症幸存者面临长期的挑战,包括ICU-获得的弱点 (ICU-AW),肌肉弱症综合征影响恢复.
- 败血症患者的ICU-AW发病率超过50%,显著影响预后和生活质量.
- 导致败血症相关的ICU-AW的因素包括炎症反应,脑病变,固定和营养不良.
研究的目的:
- 审查毒症幸存者在ICU获得的弱点的风险因素,评估方法和早期康复策略.
- 提高对ICU-AW的理解,以改善预防和患者的治疗结果.
- 专注于早期康复干预的最佳时间,内容,方法和安全性.
主要方法:
- 文献综述侧重于危险因素,风险评估和毒症的ICU-AW早期康复.
- 对ICU-AW当前的主观和新兴客观评估工具的分析.
- 审查"ABCDEF捆绑战略",重点是早期康复.
主要成果:
- 败血症相关的炎症反应,脑病变,身体固定和营养不足是ICU-AW的关键因素.
- 目前的主观风险评估工具存在局限性;客观工具正在开发中.
- 早期康复被确定为ICU-AW预防的ABCDEF捆绑战略的核心元素.
结论:
- 有效的ICU-AW预防和管理对于改善败血症幸存者的长期生活质量至关重要.
- 加强早期康复策略的理解和实施至关重要.
- 需要采取全面的方法来解决风险因素,并利用有效的评估和康复,以改善败血症患者的预后超出生存期.
更多相关视频
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
1.4K
04:01Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
Published on: June 14, 2024
594
相关概念视频
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
